This report contains market size and forecasts of Narcolepsy Treatment in Global, including the following market information:
Global Narcolepsy Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Narcolepsy Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Narcolepsy Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Narcolepsy Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Narcolepsy Treatment Market Segment Percentages, By Type, 2020 (%)
Sodium Oxybate
Antidepressants
Central Nervous System Stimulants
Others
China Narcolepsy Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Narcolepsy Treatment Market Segment Percentages, By Application, 2020 (%)
Primary Narcolepsy with Cataplexy
Primary Narcolepsy without Cataplexy
Narcolepsy Due to Medical Conditions
Unspecified Narcolepsy
Global Narcolepsy Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Narcolepsy Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Narcolepsy Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Narcolepsy Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Teva Pharmaceutical
Takeda
Jazz Pharmaceuticals
Arena Pharmaceuticals
Graymark Healthcare
Ligand Pharmaceuticals
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Narcolepsy Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Narcolepsy Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Narcolepsy Treatment Overall Market Size
2.1 Global Narcolepsy Treatment Market Size: 2021 VS 2027
2.2 Global Narcolepsy Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Narcolepsy Treatment Players in Global Market
3.2 Top Global Narcolepsy Treatment Companies Ranked by Revenue
3.3 Global Narcolepsy Treatment Revenue by Companies
3.4 Top 3 and Top 5 Narcolepsy Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Narcolepsy Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Narcolepsy Treatment Players in Global Market
3.6.1 List of Global Tier 1 Narcolepsy Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Narcolepsy Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Narcolepsy Treatment Market Size Markets, 2021 & 2027
4.1.2 Sodium Oxybate
4.1.3 Antidepressants
4.1.4 Central Nervous System Stimulants
4.1.5 Others
4.2 By Type - Global Narcolepsy Treatment Revenue & Forecasts
4.2.1 By Type - Global Narcolepsy Treatment Revenue, 2016-2021
4.2.2 By Type - Global Narcolepsy Treatment Revenue, 2022-2027
4.2.3 By Type - Global Narcolepsy Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Narcolepsy Treatment Market Size, 2021 & 2027
5.1.2 Primary Narcolepsy with Cataplexy
5.1.3 Primary Narcolepsy without Cataplexy
5.1.4 Narcolepsy Due to Medical Conditions
5.1.5 Unspecified Narcolepsy
5.2 By Application - Global Narcolepsy Treatment Revenue & Forecasts
5.2.1 By Application - Global Narcolepsy Treatment Revenue, 2016-2021
5.2.2 By Application - Global Narcolepsy Treatment Revenue, 2022-2027
5.2.3 By Application - Global Narcolepsy Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Narcolepsy Treatment Market Size, 2021 & 2027
6.2 By Region - Global Narcolepsy Treatment Revenue & Forecasts
6.2.1 By Region - Global Narcolepsy Treatment Revenue, 2016-2021
6.2.2 By Region - Global Narcolepsy Treatment Revenue, 2022-2027
6.2.3 By Region - Global Narcolepsy Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Narcolepsy Treatment Revenue, 2016-2027
6.3.2 US Narcolepsy Treatment Market Size, 2016-2027
6.3.3 Canada Narcolepsy Treatment Market Size, 2016-2027
6.3.4 Mexico Narcolepsy Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Narcolepsy Treatment Revenue, 2016-2027
6.4.2 Germany Narcolepsy Treatment Market Size, 2016-2027
6.4.3 France Narcolepsy Treatment Market Size, 2016-2027
6.4.4 U.K. Narcolepsy Treatment Market Size, 2016-2027
6.4.5 Italy Narcolepsy Treatment Market Size, 2016-2027
6.4.6 Russia Narcolepsy Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Narcolepsy Treatment Market Size, 2016-2027
6.4.8 Benelux Narcolepsy Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Narcolepsy Treatment Revenue, 2016-2027
6.5.2 China Narcolepsy Treatment Market Size, 2016-2027
6.5.3 Japan Narcolepsy Treatment Market Size, 2016-2027
6.5.4 South Korea Narcolepsy Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Narcolepsy Treatment Market Size, 2016-2027
6.5.6 India Narcolepsy Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Narcolepsy Treatment Revenue, 2016-2027
6.6.2 Brazil Narcolepsy Treatment Market Size, 2016-2027
6.6.3 Argentina Narcolepsy Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Narcolepsy Treatment Revenue, 2016-2027
6.7.2 Turkey Narcolepsy Treatment Market Size, 2016-2027
6.7.3 Israel Narcolepsy Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Narcolepsy Treatment Market Size, 2016-2027
6.7.5 UAE Narcolepsy Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Teva Pharmaceutical
7.1.1 Teva Pharmaceutical Corporate Summary
7.1.2 Teva Pharmaceutical Business Overview
7.1.3 Teva Pharmaceutical Narcolepsy Treatment Major Product Offerings
7.1.4 Teva Pharmaceutical Narcolepsy Treatment Revenue in Global (2016-2021)
7.1.5 Teva Pharmaceutical Key News
7.2 Takeda
7.2.1 Takeda Corporate Summary
7.2.2 Takeda Business Overview
7.2.3 Takeda Narcolepsy Treatment Major Product Offerings
7.2.4 Takeda Narcolepsy Treatment Revenue in Global (2016-2021)
7.2.5 Takeda Key News
7.3 Jazz Pharmaceuticals
7.3.1 Jazz Pharmaceuticals Corporate Summary
7.3.2 Jazz Pharmaceuticals Business Overview
7.3.3 Jazz Pharmaceuticals Narcolepsy Treatment Major Product Offerings
7.3.4 Jazz Pharmaceuticals Narcolepsy Treatment Revenue in Global (2016-2021)
7.3.5 Jazz Pharmaceuticals Key News
7.4 Arena Pharmaceuticals
7.4.1 Arena Pharmaceuticals Corporate Summary
7.4.2 Arena Pharmaceuticals Business Overview
7.4.3 Arena Pharmaceuticals Narcolepsy Treatment Major Product Offerings
7.4.4 Arena Pharmaceuticals Narcolepsy Treatment Revenue in Global (2016-2021)
7.4.5 Arena Pharmaceuticals Key News
7.5 Graymark Healthcare
7.5.1 Graymark Healthcare Corporate Summary
7.5.2 Graymark Healthcare Business Overview
7.5.3 Graymark Healthcare Narcolepsy Treatment Major Product Offerings
7.5.4 Graymark Healthcare Narcolepsy Treatment Revenue in Global (2016-2021)
7.5.5 Graymark Healthcare Key News
7.6 Ligand Pharmaceuticals
7.6.1 Ligand Pharmaceuticals Corporate Summary
7.6.2 Ligand Pharmaceuticals Business Overview
7.6.3 Ligand Pharmaceuticals Narcolepsy Treatment Major Product Offerings
7.6.4 Ligand Pharmaceuticals Narcolepsy Treatment Revenue in Global (2016-2021)
7.6.5 Ligand Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Narcolepsy Treatment Market Opportunities & Trends in Global Market
Table 2. Narcolepsy Treatment Market Drivers in Global Market
Table 3. Narcolepsy Treatment Market Restraints in Global Market
Table 4. Key Players of Narcolepsy Treatment in Global Market
Table 5. Top Narcolepsy Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Narcolepsy Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Narcolepsy Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Narcolepsy Treatment Product Type
Table 9. List of Global Tier 1 Narcolepsy Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Narcolepsy Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Narcolepsy Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Narcolepsy Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Narcolepsy Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Narcolepsy Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Narcolepsy Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Narcolepsy Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Narcolepsy Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Narcolepsy Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Narcolepsy Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Narcolepsy Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Narcolepsy Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Narcolepsy Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Narcolepsy Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Narcolepsy Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Narcolepsy Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Narcolepsy Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Narcolepsy Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Narcolepsy Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Narcolepsy Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Teva Pharmaceutical Corporate Summary
Table 31. Teva Pharmaceutical Narcolepsy Treatment Product Offerings
Table 32. Teva Pharmaceutical Narcolepsy Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Takeda Corporate Summary
Table 34. Takeda Narcolepsy Treatment Product Offerings
Table 35. Takeda Narcolepsy Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Jazz Pharmaceuticals Corporate Summary
Table 37. Jazz Pharmaceuticals Narcolepsy Treatment Product Offerings
Table 38. Jazz Pharmaceuticals Narcolepsy Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Arena Pharmaceuticals Corporate Summary
Table 40. Arena Pharmaceuticals Narcolepsy Treatment Product Offerings
Table 41. Arena Pharmaceuticals Narcolepsy Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Graymark Healthcare Corporate Summary
Table 43. Graymark Healthcare Narcolepsy Treatment Product Offerings
Table 44. Graymark Healthcare Narcolepsy Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Ligand Pharmaceuticals Corporate Summary
Table 46. Ligand Pharmaceuticals Narcolepsy Treatment Product Offerings
Table 47. Ligand Pharmaceuticals Narcolepsy Treatment Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Narcolepsy Treatment Segment by Type
Figure 2. Narcolepsy Treatment Segment by Application
Figure 3. Global Narcolepsy Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Narcolepsy Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Narcolepsy Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Narcolepsy Treatment Revenue in 2020
Figure 8. By Type - Global Narcolepsy Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Narcolepsy Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Narcolepsy Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Narcolepsy Treatment Revenue Market Share, 2016-2027
Figure 12. US Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Narcolepsy Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Narcolepsy Treatment Revenue Market Share, 2016-2027
Figure 24. China Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Narcolepsy Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Narcolepsy Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Narcolepsy Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Teva Pharmaceutical Narcolepsy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Takeda Narcolepsy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Jazz Pharmaceuticals Narcolepsy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Arena Pharmaceuticals Narcolepsy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Graymark Healthcare Narcolepsy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Ligand Pharmaceuticals Narcolepsy Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Teva Pharmaceutical
Takeda
Jazz Pharmaceuticals
Arena Pharmaceuticals
Graymark Healthcare
Ligand Pharmaceuticals